-transparent.png){kind=logo}
Clofibrate is a hypolipidemic agent that causes muscle protein breakdown in rats, and an acute muscular syndrome in man. It also inhibits adenylate cyclase in fat tissue. Muscle protein metabolism has been shown to be regulated by cyclic nucleotides. In the present experiments were measured several parameters of cyclic nucleotide metabolism to determine the role that cyclic nucleotides play in clofibrate-induced muscle protein degradation. It was found that clofibrate treatment did not alter cyclic nucleotide levels, nor did it change the activities of basal or hormone-stimulated adenylate cyclase, or cyclic nucleotide phosphodiesterase in muscle. Our results suggest that muscle protein breakdown in clofibrate-treated rats is not regulated by cyclic nucleotides.
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
February 1997,
The American journal of physiology,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
March 1990,
Journal of clinical pharmacology,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
September 1983,
American journal of ophthalmology,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
June 2014,
Metabolomics : Official journal of the Metabolomic Society,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
August 1989,
Agents and actions,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
June 2021,
The Journal of physiology,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
December 2000,
The Journal of physiology,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
January 1996,
Neurochemical research,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
July 2020,
The Journal of pharmacology and experimental therapeutics,
D C Lehotay, and
H S Paul, and
J S Gindler, and
S A Adibi, and
G S Levey
December 2004,
Molecular genetics and metabolism,
